NJ S3322

Requires the New Jersey Commissioner of Health to establish a central registry of newborn patients diagnosed with sickle cell trait, with laboratories documenting positive screenings and notifying the responsible physician.

Mandates physicians provide parents of newborns with sickle cell trait information about genetic counseling availability and benefits, including risks of passing the trait or disease to future children.

Establishes a notification system for parents of registry patients recommending follow-up physician consultations during early adolescence (regarding strenuous athletic activities) and later adolescence (regarding reproductive implications).

Requires the Department of Health to notify patients upon reaching age 18 of their registry inclusion and available educational services, genetic counseling, and resources.

Makes registry information confidential, with unauthorized disclosure punishable as a disorderly persons offense (up to six months imprisonment, $1,000 fine, or both per violation).